Published: Oct 02, 2021, 24:55 IST | Updated: Oct 02, 2021, 24:55 IST
Molnupiravir, an antiviral drug originally developed to treat influenza reduces hospitalisation and death from Covid-19 by 50% in patients recently infected with the virus, early trial results suggest. Watch this report for more details.